Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.

Journal of immunology (Baltimore, Md. : 1950)·1999
Same author

Regulation of endothelial cell function by pro- and anti-inflammatory cytokines.

Transplantation proceedings·1998
Same author

Regulation of chemokine receptor expression in dendritic cells.

Research in immunology·1998
Same author

The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant.

Blood·1998
Same author

Interleukin-1beta and interferon-gamma differentially regulate release of monocyte chemotactic protein-1 and interleukin-8 by human bronchial epithelial cells.

European cytokine network·1998
Same author

Regulation of chemokine receptors in mononuclear phagocytes versus dendritic cells and in the amplification of Th1 versus Th2 responses.

European cytokine network·1998

Related Experiment Video

Updated: Jun 13, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Molecular pathways linking inflammation and cancer.

A Mantovani1

  • 1Istituto Clinico Humanitas IRCCS, via Manzoni 56, 20089 Rozzano, Milan, Italy. alberto.mantovani@humanitasresearch.it

Current Molecular Medicine
|May 12, 2010
PubMed
Summary

Inflammation, even without direct links to cancer, fuels tumor growth and spread. Targeting cancer-related inflammation offers new diagnostic and therapeutic opportunities.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Inflammatory conditions are known risk factors for cancer development.
  • An inflammatory component is also found in the microenvironment of tumors not epidemiologically linked to inflammation.

Purpose of the Study:

  • To explore the molecular pathways linking inflammation and cancer.
  • To highlight the role of the tumor microenvironment in cancer progression.

Main Methods:

  • Review of recent studies on molecular pathways.
  • Analysis of components within the inflammatory tumor microenvironment, including leukocytes, cytokines, and transcription factors like NFkB and Stat3.

Main Results:

  • Two pathways link inflammation and cancer: intrinsic (neoplasia-driven) and extrinsic (inflammation-driven).

Related Experiment Videos

Last Updated: Jun 13, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

  • Chronic inflammation in the tumor microenvironment promotes cancer cell proliferation, survival, angiogenesis, metastasis, immune evasion, and resistance to therapies.

    • Conclusions:

    • Cancer-related inflammation is a critical factor in tumor development and progression.
    • Targeting cancer-related inflammation presents promising avenues for novel diagnostic and therapeutic strategies.